AKR1B1 and colorectal carcinoma: These two CMS types are known to be rich in either desmoplastic stroma or immune cells in the TME; thus, this led us to hypothesize that the stromal compartment of CRC tumors may contribute toward oncogenic signaling in AKR1B1 expressing tumors.